首页|水陆二仙丹联合抵挡汤加减方对早中期糖尿病肾病患者的临床疗效

水陆二仙丹联合抵挡汤加减方对早中期糖尿病肾病患者的临床疗效

扫码查看
目的 探讨水陆二仙丹联合抵挡汤加减方对早中期糖尿病肾病患者的临床疗效.方法 83 例患者随机分为对照组(42 例)和观察组(41 例),对照组给予厄贝沙坦片,观察组在对照组基础上加用水陆二仙丹联合抵挡汤加减方,疗程 12 周.检测临床疗效、中医证候评分、血糖指标(FBG、HbA1c)、血脂指标(TC、TG)、肾功能指标(BUN、Scr、24 h UTP、eGFR)、炎症因子(IL-1β、hs-CRP、IL-6、TNF-α、IL-18、TGF-β1)、免疫功能指标(淋巴细胞、中性粒细胞、CD8+、CD3+、CD4+、CD4+/CD8+)、不良反应发生率变化.结果 观察组总有效率高于对照组(P<0.05).治疗后,观察组中医证候评分、血糖指标、血脂指标、BUN、Scr、24 h UTP、炎症因子、CD8+降低(P<0.05),淋巴细胞、中性粒细胞减少(P<0.05),eGFR、CD3+、CD4+、CD4+/CD8+升高(P<0.05),并比对照组更明显(HbA1c、TG、SCr、24 h UTP、淋巴细胞、中性粒细胞除外)(P<0.05).2 组不良反应发生率比较,差异无统计学意义(P>0.05).结论 水陆二仙丹联合抵挡汤加减方可安全有效地改善早中期糖尿病肾病患者临床症状,其机制可能与降低炎症水平、改善机体免疫功能有关.
Clinical effects of Shuilu Erxian Pills combined with Modified Didang Decoction on patients with early and middle stage diabetic nephropathy
AIM To explore the clinical effects of Shuilu Erxian Pills combined with Modified Didang Decoction on patients with early and middle stage diabetic nephropathy.METHODS Eighty-three patients were randomly assigned into control group(42 cases)for 12-week administration of Irbesartan Tablets,and observation group(41 cases)for 12-week administration of Shuilu Erxian Pills,Modified Didang Decoction and Irbesartan Tablets.The changes in clinical effects,TCM syndrome scores,blood glucose indices(FBG,HbA1c),blood lipid indices(TC,TG),renal function indices(BUN,Scr,24 h UTP,eGFR),inflammatory factors(IL-1β,hs-CRP,IL-6,TNF-α,IL-18,TGF-β1),immune function indices(lymphocyte,neutrophil,CD8+,CD3+,CD4+,CD4+/CD8+)and incidence of adverse reactions were detected.RESULTS The observation group demonstrated higher total effective rate than the control group(P<0.05).After the treatment,the observation group displayed decreased TCM syndrome scores,blood glucose indices,blood lipid indices,BUN,Scr,24 h UTP,inflammatory factors,CD8+(P<0.05),reduced lymphocyte,neutrophil(P<0.05),and increased eGFR,CD3+,CD4+,CD4+/CD8+(P<0.05),which were more obvious than those in the control group(except for HbA1c,TG,SCr,24 h UTP,lymphocyte,neutrophil)(P<0.05).No significant difference in incidence of adverse reactions was found between the two groups(P>0.05).CONCLUSION For the patients with early and middle stage diabetic nephropathy,Shuilu Erxian Pills combined with Modified Didang Decoction can safely and effectively improve clinical symptoms,whose mechanism may contribute to the reduction of inflammatory levels and improvement of immune functions.

Shuilu Erxian PillsModified Didang DecoctionIrbesartan Tabletsearly and middle stage diabetic nephropathy

郭建恩、张佳华、张园、纪品川、高志旭、高占华、安丽萍、杨佳琦、常柏

展开 >

天津中医药大学研究生院,天津 301617

承德医学院,河北 承德 067000

承德市中医院,河北 承德 067000

天津医科大学朱宪彝纪念医院,天津 300070

展开 >

水陆二仙丹 抵挡汤加减方 厄贝沙坦片 早中期糖尿病肾病

国家自然科学基金河北省自然科学基金河北省中医药局科研项目

81973614H20224060692023139

2024

中成药
国家食品药品监督管理局,信息中心中成药信息站,上海中药行业协会

中成药

CSTPCD北大核心
影响因子:1.217
ISSN:1001-1528
年,卷(期):2024.46(5)
  • 21